
Glyzee PM1 Tablet ER
Marketer
Zeelab Pharmacy Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glyzee PM1 Tablet ER
DiabetaCare ER is a dual-action medication designed to manage blood glucose. This medication complements a healthy diet and exercise program to enhance blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. DiabetaCare ER should be administered precisely as prescribed by your physician, both in terms of dosage and duration. Taking it with food minimizes potential stomach discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. An overdose can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing mothers must consult their physician before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption, as it may increase the likelihood of side effects.
Primary Ingredients of Glyzee PM1 Tablet ER
There is no text provided to rephrase.
Uses of Glyzee PM1 Tablet ER
Managing type 2 diabetes
Major Benefits of Glyzee PM1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glyzee PM1 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with food.
Common Side effects of Glyzee PM1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glyzee PM1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyzee PM1 Extended-Release tablets should be taken with meals.
How Glyzee PM1 Tablet ER works:
Glyzee PM1 ER tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone to manage blood sugar levels. These medications employ distinct mechanisms to enhance glycemic control when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glyzee PM1 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glyzee PM1 Extended-Release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Postpartum use of Glyzee PM1 Extended-Release tablets is likely inadvisable while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glyzee PM1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glyzee PM1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Glyzee PM1 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Glyzee PM1 Tablet ER is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Glyzee PM1 Tablet ER :
Should you forget a Glyzee PM1 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glyzee PM1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
